CMP Pharma, Inc Announces That CaroSpir®, The First And Only FDA-Approved Spironolactone Oral Suspension, Is Now Available

Farmville, NC. October 30, 2017 CMP Pharma today announced that CaroSpir® (Spironolactone Oral Suspension, 25 mg/5 mL), the first and only FDA-approved oral liquid dosage form of the potassium-sparing diuretic spironolactone, is now available. CaroSpir was approved by the FDA…

Investment in G&H Orthodontics

Altaris Capital Partners, LLC (“Altaris”) announces an investment in G&H Orthodontics. G&H Orthodontics is a global designer, manufacturer and distributor of clinical orthodontia products. Headquartered in Franklin, IN, G&H sells a full suite of American-made orthodontic brackets, bands, tubes, wires,…